Holen Sie sich die Stockscreener-App
73.47
1.67%
1.21
Schlusskurs vom Vortag:
$72.26
Offen:
$72.97
24-Stunden-Volumen:
686.74K
Relative Volume:
0.80
Marktkapitalisierung:
$7.74B
Einnahmen:
$628.56M
Nettoeinkommen (Verlust:
$141.82M
KGV:
58.31
EPS:
1.26
Netto-Cashflow:
$142.60M
1W Leistung:
+1.31%
1M Leistung:
-11.60%
6M Leistung:
+2.21%
1J Leistung:
+50.03%
1-Tages-Spanne:
$72.47
$74.22
1-Wochen-Bereich:
$70.89
$74.77
52-Wochen-Spanne:
$46.38
$117.33
Corcept Therapeutics Inc Stock (CORT) Company Profile
Firmenname
Corcept Therapeutics Inc
Sektor
Branche
Telefon
650.688.8803
Adresse
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Vergleichen Sie CORT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
73.47 | 7.61B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-06 | Hochstufung | Truist | Hold → Buy |
| 2023-04-11 | Eingeleitet | SVB Securities | Market Perform |
| 2023-04-04 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-01 | Herabstufung | Truist | Buy → Hold |
| 2022-07-27 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-27 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2020-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-24 | Eingeleitet | Jefferies | Buy |
| 2019-09-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-02-04 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | Bestätigt | Stifel | Hold |
| 2018-05-31 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-09 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | Eingeleitet | Stifel | Buy |
| 2017-02-02 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2015-04-21 | Eingeleitet | FBR Capital | Outperform |
| 2014-01-13 | Herabstufung | Stifel | Buy → Hold |
| 2013-08-09 | Herabstufung | Janney | Buy → Neutral |
| 2013-08-09 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-01-06 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | Hochstufung | Punk, Ziegel & Co | Mkt Perform → Accumulate |
Alle ansehen
Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten
Y Intercept Hong Kong Ltd Purchases 11,881 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Does Corcept Therapeutics Incorporated qualify in momentum factor screeningJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
What hedge fund moves indicate for Corcept Therapeutics Incorporated (HTD) stock - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock a top pick for value investorsPortfolio Return Report & Consistent Income Trade Ideas - newser.com
How hedge fund analytics apply to Corcept Therapeutics Incorporated stockGold Moves & Fast Entry Momentum Trade Alerts - newser.com
Will Corcept Therapeutics Incorporated (HTD) stock enhance shareholder valuePrice Action & AI Forecasted Entry/Exit Points - newser.com
Is Corcept Therapeutics Incorporated stock positioned well for digital economyMarket Performance Summary & Daily Entry Point Alerts - newser.com
Using Bollinger Bands to evaluate Corcept Therapeutics IncorporatedJobs Report & Daily Entry Point Trade Alerts - newser.com
Corcept Therapeutics Inc expected to post earnings of 14 cents a shareEarnings Preview - TradingView
Is Corcept Therapeutics Incorporated stock affected by interest rate hikesTrade Risk Assessment & Low Risk High Reward Ideas - newser.com
Emerald Mutual Fund Advisers Trust Acquires 113,088 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
How Corcept Therapeutics Incorporated stock compares to growth peersQuarterly Profit Report & Long-Term Investment Growth Plans - newser.com
Will Corcept Therapeutics Incorporated stock recover faster than market2025 Short Interest & Fast Gaining Stock Reports - newser.com
Does Corcept Therapeutics Incorporated (HTD) stock trade below intrinsic valueMarket Activity Summary & Technical Entry and Exit Alerts - newser.com
How reliable is Corcept Therapeutics Incorporated (HTD) stock dividend growthMarket Risk Report & Fast Moving Stock Watchlists - newser.com
What momentum indicators show for Corcept Therapeutics Incorporated stock2025 Top Gainers & Reliable Volume Spike Trade Alerts - newser.com
What Corcept Therapeutics (CORT)'s Phase 3 Relacorilant Data Means for Shareholders - Yahoo Finance
Using data models to predict Corcept Therapeutics Incorporated stock movementPortfolio Profit Report & Long-Term Growth Plans - newser.com
Emerald Advisers LLC Purchases 179,871 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Risk vs reward if holding onto Corcept Therapeutics IncorporatedPortfolio Value Report & Accurate Trade Setup Notifications - newser.com
Identifying reversal signals in Corcept Therapeutics IncorporatedJuly 2025 Movers & Real-Time Volume Analysis Alerts - newser.com
Will Corcept Therapeutics Incorporated (HTD) stock extend growth storyRate Hike & Fast Exit Strategy with Risk Control - newser.com
Detecting support and resistance levels for Corcept Therapeutics IncorporatedAnalyst Upgrade & Community Supported Trade Ideas - newser.com
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call - BioSpace
Is Corcept Therapeutics Incorporated stock dividend yield sustainableProfit Target & Safe Capital Allocation Plans - fcp.pa.gov.br
Why analysts upgrade Corcept Therapeutics Incorporated stockQuarterly Risk Review & Daily Oversold Stock Bounce Ideas - fcp.pa.gov.br
Key metrics from Corcept Therapeutics Incorporated’s quarterly dataJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock attractive for growth fundsQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com
Is Corcept Therapeutics Incorporated stock a buy before product launchesBreakout Watch & Verified Momentum Watchlists - Fundação Cultural do Pará
Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
What indicators show strength in Corcept Therapeutics IncorporatedAnalyst Downgrade & High Yield Stock Recommendations - newser.com
Finanzdaten der Corcept Therapeutics Inc-Aktie (CORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):